所属领域：
抗突发性传染病药物研发
资源类型：
指南法规
/ 中国
文献作者：
X. Y. Xu, H. G. Ding, W. G. Li, J. D. Jia, L. Wei, Z. P. Duan, Y. L. Liu, E. Q. Ling-Hu, H. Zhuang, C. S. O. Hepatology and C. M. Association
文献发表年份：
2019
文献期刊：
World J Gastroenterol
文献摘要： The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of hepatic encephalopathy (HE) including minimal hepatic encephalopathy (MHE) and overt hepatic encephalopathy, emphasizing the importance on screening MHE in patients with end-stage liver diseases. The guidelines emphasized that early identification and timely treatment are the key to improve the prognosis of HE. The principles of treatment include prompt removal of the cause, recovery of acute neuropsychiatric abnormalities to baseline status, primary prevention, and secondary prevention as soon as possible.
